A group of factors including other immune checkpoints [21–23], cancer neoantigens [24–26], gut microbiota [27, 28], soluble MHC related molecules [29], and cytokines in the tumor microenvironment (TME) also affect anti-cancer immune response [30, 31]. The gene discussed is HLA-C; the disease is cancer.